BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:U.S. CDMRP – Multiple Sclerosis Research Program | Research Fund
 ing
DTSTART;VALUE=DATE:20260730
DTSTAMP:20261117T135317Z
UID:20c6dcd5b8ecab7bad8484b5fc608ff3422c27ef783620984ee50656
CATEGORIES:Call for proposal
DESCRIPTION:Aim: Through the Congressionally Directed Medical Research Pro
 gram (CDMRP)\, the Department of Defense is announcing the 2026 Multiple S
 clerosis Research Program (MSRP) Awards. Several award programs are avail
 able:\n\n	The Clinical Trial Award supports the implementation of clinical
  trials with the potential to significantly impact the treatment and manag
 ement of multiple sclerosis. Funding Level 1 supports small-scale proof-of
 -principle studies\, while Funding Level 2 supports larger phase I/II clin
 ical trials aimed at demonstrating safety or preliminary efficacy. Applica
 tions must include preliminary data\n	The Early Investigator Research Awar
 d supports multiple sclerosis-focused research opportunities for investiga
 tors in the early stages of their careers. Applicants must work under the 
 mentorship of an experienced MS researcher and dedicate at least 50% effor
 t to the project.\n	The Exploration - Hypothesis Development Award support
 s the initial exploration of innovative\, high-risk\, high-gain\, and pote
 ntially groundbreaking concepts in multiple sclerosis research. Preliminar
 y data are not required\, and the strength of the application is expected 
 to rely primarily on the proposed research approach. A New Investigator Op
 tion is available for early-career faculty researchers.\n	The Investigator
 -Initiated Research Award supports highly rigorous\, high-impact research 
 projects with the potential to make an important contribution to multiple 
 sclerosis research and/or patient care. Applications must include relevant
  preliminary data. A New Investigator Option is available for researchers 
 early in their independent careers. Clinical trials are not permitted.\n\n
 All applications must specifically address at least one of the Focus Areas
  specified for the relevant award mechanism and  listed in this document.
 \n\nFunding:       Clinical Trial Award: $1M – $2M\nEarly Investiga
 tor Research Award: up to $300K\nExploration - Hypothesis Development Awar
 d: up to $250K\nInvestigator-Initiated Research Award: up to $1M\n\nNote: 
 Cost caps are total costs (direct plus indirect costs). In accordance wi
 th EPFL guidelines\, budgets should include a 20% overhead\, and the total
  budget must remain within the grant’s maximum allowable funding\n\nDura
 tion:     \nClinical Trial Award: 3-4 years\nEarly Investigator Resear
 ch Award: 2 years\nExploration - Hypothesis Development Award: 2 years\nIn
 vestigator-Initiated Research Award: 3 years\n\nEligibility: Applicants fr
 om international organizations or institutions are eligible to apply\, and
  there are no citizenship restrictions. Eligibility requirements vary by a
 ward mechanism\; independent investigators are eligible to apply\, while t
 he Early Investigator Research Award is specifically intended for research
 ers in the early stages of their careers.\n\nHow to Apply: Pre-application
 s are submitted through the eBRAP platform. They should contain contact in
 formation\, a pre-proposal or letter of intent\, and a list of collaborato
 rs and key personnel as suggested on the platform. Full applications will 
 be made via a Grants.gov workspace.\n\nPre-Application Deadline:     
        30 July 2026\, 5:00 p.m. Eastern time\nFull Application Deadl
 ine:           13 August 2026\, 11:59 p.m Eastern Time       
                                                  
   \n\nFurther information:\n\n\n	To find the full program announcements 
 and to start your pre-application see here\n	A useful summary of each call
  can be found here\n	For questions about the eBRAP or Grants.gov platforms
 \, contact the Research Office.\n	Grants.gov Funding Opportunity Numbers:\
 n	\n		Clinical Trial Award: HT942526MSRPCTA\n		Early Investigator Research
  Award: HT942526MSRPEIRA\n		Exploration - Hypothesis Development Award: HT
 942526MSRPEHDA\n		Investigator-Initiated Research Award: HT942526MSRPIIRA\
 n	\n	\n
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR
